Get the Stockscreener App
8.36
1.95%
0.16
111 Inc Adr stock is traded at $8.36, with a volume of 49,680.
It is up +1.95% in the last 24 hours and up +93.92% over the past month.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
See More
Previous Close:
$8.20
Open:
$8.12
24h Volume:
49,680
Relative Volume:
1.48
Market Cap:
$71.62M
Revenue:
$2.05B
Net Income/Loss:
$-45.99M
P/E Ratio:
-14.84
EPS:
-0.5634
Net Cash Flow:
$5.54M
1W Performance:
+9.28%
1M Performance:
+93.92%
6M Performance:
-10.16%
1Y Performance:
-37.14%
1-Day Range:
$8.10
$8.40
1-Week Range:
$7.70
$8.81
52-Week Range:
$4.145
$15.80
111 Inc Adr Stock (YI) Company Profile
Compare YI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
YI
111 Inc Adr
|
8.36 | 71.62M | 2.05B | -45.99M | 5.54M | -0.5634 |
|
MCK
Mckesson Corporation
|
597.71 | 74.91B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
241.43 | 46.77B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
127.06 | 30.95B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
77.24 | 9.32B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.07 | 2.73B | 6.55B | 155.22M | -823.13M | 1.71 |
111 Inc Adr Stock (YI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Resumed | Citigroup | Buy |
111 Inc Adr Stock (YI) Latest News
When Will 111's Healthcare Platform Report Q4 Earnings? Key Details for Investors - StockTitan
111 (NASDAQ:YI) Earns Sell (E+) Rating from Weiss Ratings - Defense World
111 (NASDAQ:YI) Given "Sell (E+)" Rating at Weiss Ratings - MarketBeat
Savant Capital LLC Buys 111 Shares of Essex Property Trust, Inc. (NYSE:ESS) - Defense World
111, Inc. (NASDAQ:YI) Sees Significant Increase in Short Interest - MarketBeat
111, Inc. (NASDAQ:YI) Short Interest Update - Defense World
111 Inc regains Nasdaq compliance with share price By Investing.com - Investing.com South Africa
111, Inc. meets NASDAQ's listing standards again - Investing.com
111, Inc. Regains NASDAQ Compliance - TipRanks
111 Inc regains Nasdaq compliance with share price - Investing.com
Chinese Healthcare Giant 111, Inc. Defeats Delisting Threat as NASDAQ Confirms Compliance - StockTitan
Qlaris Bio Announces Positive Topline Data From Two Phase II Trials of QLS-111 in Patients With Primary Open Angle Glaucoma and Ocular Hypertension - BioSpace
United Parcel Service, Inc (UPS)’s Day in Review: Closing at 111.29, Down by -2.57 - The Dwinnex
111’s (YI) Sell (E+) Rating Reaffirmed at Weiss Ratings - Defense World
111, Inc. (NASDAQ:YI) Short Interest Down 83.4% in January - MarketBeat
Short Interest in 111, Inc. (NASDAQ:YI) Expands By 167.4% - Defense World
King Charles III | Biography, Prince, Wife, Cancer, & Age - Britannica
UMB Bank n.a. Acquires 111 Shares of NetEase, Inc. (NASDAQ:NTES) - Defense World
Boston Scientific Corp (BSX): AI-Driven Innovation and Barclays’ Bullish $111 Price Target - Insider Monkey
Activist Investor 111 Equity Takes 5.17% Stake in Matinas BioPharma, Seeks Value Creation - StockTitan
Tech founder and his wife allegedly stole millions to pay for a lavish wedding, a new Tesla, and private schools—while failing to even make payroll for employees - Fortune
IIIInformation Services Group, Inc. Latest Stock News & Market Updates - StockTitan
Weiss Ratings Reiterates “Sell (E+)” Rating for 111 (NASDAQ:YI) - Defense World
Shelton Wealth Management LLC Sells 111 Shares of Booking Holdings Inc. (NASDAQ:BKNG) - MarketBeat
Warren pushes for Hegseth’s wife to divest from defense company stocks - The Hill
Lorain adds former golf club to demolition list - Chronicle Telegram
Regenxbio Secures A Partnership With Nippon Shinyaku For RGX-111 & 121 - Seeking Alpha
Short Interest in Expion360 Inc. (NASDAQ:XPON) Increases By 42.4% - Defense World
XWELL, Inc. (NASDAQ:XWEL) Short Interest Update - Defense World
Short Interest in Zhongchao Inc. (NASDAQ:ZCMD) Drops By 34.6% - Defense World
Short Interest in XTI Aerospace, Inc. (NASDAQ:XTIA) Decreases By 98.8% - Defense World
Netcall plc (LON:NET) Insider Henrik Bang Sells 1,717,000 Shares - Defense World
ZK International Group Co., Ltd. (NASDAQ:ZKIN) Short Interest Down 25.3% in December - Defense World
Zoomcar Holdings, Inc. (NASDAQ:ZCARW) Sees Large Increase in Short Interest - Defense World
ZoomInfo Technologies Inc. (NASDAQ:ZI) Sees Significant Decrease in Short Interest - Defense World
REGENXBIO Lands $810M Gene Therapy Deal with Nippon Shinyaku for Rare Disease Treatments - StockTitan
N2OFF's 111 MWp Solar Project in Germany Secures Key Municipal Approval, Advances Toward RTB Status - StockTitan
111 Stock Scheduled to Reverse Split on Friday, January 24th (NASDAQ:YI) - Defense World
Here are businesses on the move in Napa, Marin, Solano and Sonoma counties - North Bay Business Journal
111 Inc. announces change to ADS ratio - Investing.com
111, Inc. Announces Change in ADS Ratio to Enhance Market Operations - TipRanks
111 Inc Announces 1-for-10 Reverse ADS Split, Major Ratio Change Coming January 2025 - StockTitan
It’s time to start removing highways. For real this time - Fast Company
Alphabet Inc. (NASDAQ:GOOG) Director Sells $21,366.39 in Stock - MarketBeat
N2OFF's 111 MWp Solar Project Advances in Germany, Secures Key Municipal Approval - StockTitan
Short Interest in 111, Inc. (NASDAQ:YI) Decreases By 41.3% - MarketBeat
111, Inc. (NASDAQ:YI) Short Interest Down 41.3% in December - Defense World
Ultragenyx Submits Biologics License Application to the U.S. FDA for UX111 AAV Gene Therapy for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA) - GlobeNewswire
Biomea Fusion Announces Positive Topline Results from - GlobeNewswire
Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes - Yahoo Finance
Biomea Fusion to Unveil Key Phase II Diabetes Trial Results: COVALENT-111 Data Release Set for December - StockTitan
111 Inc Adr Stock (YI) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):